GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » EV-to-FCF

G Medical Innovations Holdings (G Medical Innovations Holdings) EV-to-FCF : -0.11 (As of Jun. 10, 2024)


View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, G Medical Innovations Holdings's Enterprise Value is $2.17 Mil. G Medical Innovations Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2022 was $-20.60 Mil. Therefore, G Medical Innovations Holdings's EV-to-FCF for today is -0.11.

The historical rank and industry rank for G Medical Innovations Holdings's EV-to-FCF or its related term are showing as below:

GMVDF's EV-to-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 26.54
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-10), G Medical Innovations Holdings's stock price is $0.0107. G Medical Innovations Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-32.773. Therefore, G Medical Innovations Holdings's PE Ratio for today is At Loss.


G Medical Innovations Holdings EV-to-FCF Historical Data

The historical data trend for G Medical Innovations Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings EV-to-FCF Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial -869.31 -1,959.72 -13,143.66 -2.30 -0.47

G Medical Innovations Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13,143.66 - -2.30 - -0.47

Competitive Comparison of G Medical Innovations Holdings's EV-to-FCF

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's EV-to-FCF falls into.



G Medical Innovations Holdings EV-to-FCF Calculation

G Medical Innovations Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2.165/-20.6
=-0.11

G Medical Innovations Holdings's current Enterprise Value is $2.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. G Medical Innovations Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2022 was $-20.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G Medical Innovations Holdings  (OTCPK:GMVDF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

G Medical Innovations Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0107/-32.773
=At Loss

G Medical Innovations Holdings's share price for today is $0.0107.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. G Medical Innovations Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-32.773.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


G Medical Innovations Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
Executives
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022

G Medical Innovations Holdings (G Medical Innovations Holdings) Headlines

From GuruFocus